Profile data is unavailable for this security.
About the company
CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company conducts its business in the domestic and overseas markets.
- Revenue in HKD (TTM)95.51m
- Net income in HKD-593.11m
- Incorporated2018
- Employees371.00
- LocationCARsgen Therapeutics Holdings Ltd1F, Building 2,No. 466 Yindu Road, XuhuSHANGHAI ChinaCHN
- Websitehttps://www.carsgen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Visen Pharmaceuticals | -100.00bn | -100.00bn | 3.65bn | 54.00 | -- | 3.46 | -- | -- | -- | -- | -- | 9.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0014 | -- | -- | -- | 26.98 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 364.06m | -217.95m | 3.70bn | 337.00 | -- | 14.24 | -- | 10.17 | -0.9813 | -0.9813 | 1.64 | 1.16 | 0.2903 | 4.05 | 9.14 | 1,073,926.00 | -17.90 | -- | -28.45 | -- | 72.44 | -- | -61.64 | -- | 1.43 | -23.19 | 0.7466 | -- | -- | -- | 33.91 | -- | -- | -- |
| TYK Medicines Inc | 121.60k | -318.29m | 4.10bn | 163.00 | -- | 9.87 | -- | 33,756.94 | -0.8583 | -0.8583 | 0.0003 | 1.09 | 0.0002 | -- | -- | 794.75 | -42.68 | -- | -- | -- | 13.08 | -- | -263,981.30 | -- | -- | -- | 0.3215 | -- | -- | -- | -1.18 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 228.84m | -51.88m | 4.37bn | 211.00 | -- | 4.44 | -- | 19.08 | -0.067 | -0.067 | 0.2958 | 1.25 | 0.1547 | -- | 7.97 | 890,433.90 | -3.51 | -36.09 | -4.01 | -39.58 | 100.00 | 65.67 | -22.67 | -283.16 | -- | -- | 0.1415 | -- | 145.13 | -- | 56.64 | -- | 29.33 | -- |
| MiRXES Holding Co Ltd | -100.00bn | -100.00bn | 4.55bn | 347.00 | -- | 5.10 | -- | -- | -- | -- | -- | 2.99 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.83 | -- | 0.1682 | -- | -16.14 | -- | -33.37 | -- | -- | -- |
| Laekna Inc | 0.00 | -273.00m | 5.02bn | 84.00 | -- | 5.66 | -- | -- | -0.7423 | -0.7423 | 0.00 | 1.99 | 0.00 | -- | -- | 0.00 | -27.79 | -- | -34.25 | -- | -- | -- | -- | -- | -- | -- | 0.1383 | -- | -- | -- | 31.05 | -- | -- | -- |
| Edding Genor Group Holdings Ltd | 254.56m | 22.89m | 5.12bn | 17.00 | 56.76 | 1.08 | 146.75 | 20.12 | 0.0451 | 0.0451 | 0.4902 | 2.38 | 0.1724 | -- | 5.21 | 10,606,700.00 | 1.46 | -48.63 | 1.72 | -55.19 | 99.56 | 97.88 | 8.45 | -2,303.07 | -- | -- | 0.0007 | -- | -- | 73.71 | 92.40 | -- | -43.79 | -- |
| CARsgen Therapeutics Holdings Ltd | 95.51m | -593.11m | 6.95bn | 371.00 | -- | 6.42 | -- | 72.73 | -1.08 | -1.08 | 0.1736 | 1.90 | 0.0465 | 5.13 | 7.63 | 204,083.10 | -28.88 | -76.51 | -32.44 | -89.25 | 50.57 | -- | -621.16 | -12,640.86 | 6.40 | -- | 0.0672 | -- | -- | -- | -6.73 | -- | -28.32 | -- |
| Lepu Biopharma Co Ltd | 796.00m | -201.37m | 7.36bn | 546.00 | -- | 8.24 | -- | 9.25 | -0.1177 | -0.1177 | 0.4653 | 0.4951 | 0.2917 | 2.35 | 18.33 | 1,598,400.00 | -8.24 | -24.70 | -14.39 | -37.71 | 88.41 | -- | -28.26 | -459.37 | 0.5915 | -5.03 | 0.5632 | -- | 63.21 | -- | -1,761.77 | -- | -29.86 | -- |
| Abbisko Cayman Ltd | 695.62m | 62.78m | 7.50bn | 220.00 | 127.77 | 3.43 | 19.40 | 10.78 | 0.0873 | 0.0873 | 1.10 | 3.25 | 0.2745 | -- | -- | 3,161,906.00 | 2.48 | -24.40 | 2.83 | -25.96 | 100.00 | 100.00 | 9.03 | -229.19 | -- | -- | 0.1363 | -- | 21.45 | -- | 95.21 | -- | -- | -- |
| Alphamab Oncology | 893.17m | 264.57m | 7.68bn | 484.00 | 30.08 | 3.61 | 22.22 | 8.60 | 0.2636 | 0.2636 | 0.8975 | 2.20 | 0.3492 | 0.8254 | 23.76 | 2,126,606.00 | 10.35 | -9.96 | 12.30 | -11.75 | 92.27 | -- | 29.62 | -103.28 | 4.75 | -- | 0.1285 | -- | 192.58 | -- | 178.99 | -- | -33.81 | -- |
| GenFleet Therapeutics (Shanghai) Inc | 219.84m | -1.05bn | 9.27bn | 94.00 | -- | -- | -- | 42.19 | -3.05 | -3.05 | 0.6366 | -8.69 | -- | -- | -- | -- | -- | -- | -- | -- | 80.86 | -- | -479.17 | -- | 0.1655 | -23.43 | -- | -- | 42.00 | -- | -33.31 | -- | -- | -- |
| Suzhou Ribo Life Science Co Ltd | 204.71m | -250.84m | 10.40bn | 404.00 | -- | -- | -- | 50.82 | -1.55 | -1.55 | 1.27 | -0.4107 | -- | -- | -- | -- | -- | -- | -- | -- | 90.90 | -- | -131.95 | -- | 0.9173 | -14.93 | 0.8949 | -- | 324,052.30 | -- | 36.93 | -- | -- | -- |
Data as of Mar 05 2026. Currency figures normalised to CARsgen Therapeutics Holdings Ltd's reporting currency: Hong Kong Dollar HKD
4.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 14.27m | 2.47% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 6.22m | 1.08% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 1.23m | 0.21% |
| JPMorgan Asset Management (UK) Ltd.as of 30 Jun 2025 | 1.05m | 0.18% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 942.50k | 0.16% |
| Goldman Sachs Asset Management LPas of 31 Oct 2025 | 645.50k | 0.11% |
| Vanguard Fiduciary Trust Co.as of 31 Jan 2026 | 408.50k | 0.07% |
| BlackRock Fund Advisorsas of 05 Feb 2026 | 346.00k | 0.06% |
| Bellecapital AGas of 30 Jun 2025 | 320.00k | 0.06% |
| TIAA-CREF Investment Management LLCas of 31 Dec 2025 | 310.50k | 0.05% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
